CoChat
Sign Up
Cited by 216Genetic Associations and EpidemiologyDiabetes, Cardiovascular Risks, and LipoproteinsNutrition, Genetics, and Disease

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Causal Effects of Body Mass Index on Cardiometabolic Traits and Events: A Mendelian Randomization Analysis

Open access
Holmes, Michael V., Lange, Leslie A., Palmer, Tom, Lanktree, Matthew B., North, Kari E., Almoguera, Berta, Buxbaum, Sarah, Chandrupatla, Hareesh R., Elbers, Clara C., Guo, Yiran, Hoogeveen, Ron C., Li, Jin, Li, Yun R., Swerdlow, Daniel I., Cushman, Mary, Price, Tom S., Curtis, Sean P., Fornage, Myriam, Hakonarson, Hakon, Patel, Sanjay R., Redline, Susan, Siscovick, David S., Tsai, Michael Y., Wilson, James G., van der Schouw, Yvonne T., FitzGerald, Garret A., Hingorani, Aroon D., Casas, Juan P., de Bakker, Paul I.W., Rich, Stephen S., Schadt, Eric E., Asselbergs, Folkert W., Reiner, Alex P., Keating, Brendan J.·2014·The American Journal of Human Genetics
DOI 10.1016/j.ajhg.2013.12.014PMC PMC3928659
Open this paper in CoChat — free accountOpen PDF

Abstract

Elevated body mass index (BMI) associates with cardiometabolic traits on observational analysis, yet the underlying causal relationships remain unclear. We conducted Mendelian randomization analyses by using a genetic score (GS) comprising 14 BMI-associated SNPs from a recent discovery analysis to investigate the causal role of BMI in cardiometabolic traits and events. We used eight population-based cohorts, including 34,538 European-descent individuals (4,407 type 2 diabetes (T2D), 6,073 coronary heart disease (CHD), and 3,813 stroke cases). A 1 kg/m(2) genetically elevated BMI increased fasting glucose (0.18 mmol/l; 95% confidence interval (CI) = 0.12-0.24), fasting insulin (8.5%; 95% CI = 5.9-11.1), interleukin-6 (7.0%; 95% CI = 4.0-10.1), and systolic blood pressure (0.70 mmHg; 95% CI = 0.24-1.16) and reduced high-density lipoprotein cholesterol (-0.02 mmol/l; 95% CI = -0.03 to -0.01) and low-density lipoprotein cholesterol (LDL-C; -0.04 mmol/l; 95% CI = -0.07 to -0.01). Observational and causal estimates were directionally concordant, except for LDL-C. A 1 kg/m(2) genetically elevated BMI increased the odds of T2D (odds ratio [OR] = 1.27; 95% CI = 1.18-1.36) but did not alter risk of CHD (OR 1.01; 95% CI = 0.94-1.08) or stroke (OR = 1.03; 95% CI = 0.95-1.12). A meta-analysis incorporating published studies reporting 27,465 CHD events in 219,423 individuals yielded a pooled OR of 1.04 (95% CI = 0.97-1.12) per 1 kg/m(2) increase in BMI. In conclusion, we identified causal effects of BMI on several cardiometabolic traits; however, whether BMI causally impacts CHD risk requires further evidence.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ajhg.2013.12.014

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

Sorted by citations

Items 101–200 of 216

Related

See all

Metadata

Authors
Holmes, M. V., Lange, L. A., Palmer, T., Lanktree, M. B., North, K. E., Almoguera, B., Buxbaum, S., Chandrupatla, H. R., Elbers, C. C., Guo, Y., Hoogeveen, R. C., Li, J., Li, Y. R., Swerdlow, D. I., Cushman, M., Price, T. S., Curtis, S. P., Fornage, M., Hakonarson, H., Patel, S. R., Redline, S., Siscovick, D. S., Tsai, M. Y., Wilson, J. G., van der Schouw, Y. T., FitzGerald, G. A., Hingorani, A. D., Casas, J. P., de Bakker, P. I. W., Rich, S. S., Schadt, E. E., Asselbergs, F. W., Reiner, A. P., & Keating, B. J.
Affiliations
  • University College London (GB)
  • University of North Carolina at Chapel Hill (US)
  • University of Warwick (GB)
  • McMaster University (CA)
  • Children's Hospital of Philadelphia (US)
  • Jackson State University (US)
  • University Medical Center Utrecht (NL)
  • Baylor College of Medicine (US)
  • University of Vermont (US)
  • University of Pennsylvania (US)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • The University of Texas Health Science Center at Houston (US)
  • Brigham and Women's Hospital (US)
  • University of Washington (US)
  • University of Minnesota (US)
  • University of Mississippi Medical Center (US)
  • London School of Hygiene & Tropical Medicine (GB)
  • University of Virginia (US)
  • Icahn School of Medicine at Mount Sinai (US)
  • Fred Hutch Cancer Center (US)
Corresponding author
  • Holmes, Michael V.
  • Keating, Brendan J.
ORCID
Venue
The American Journal of Human Genetics
Publisher
Elsevier BV
Published
2014-02
Volume
94
Issue
2
Pages
198-208
ISSN
0002-9297 (ISSN-L)
DOI
10.1016/j.ajhg.2013.12.014
PMC
PMC3928659
OpenAlex
W2005648153
Cited by
216
References
57
Citations by year
2026: 5 · 2025: 9 · 2024: 10 · 2023: 11 · 2022: 14 · 2021: 15 · 2020: 16 · 2019: 21 · 2018: 30 · 2017: 23 · 2016: 26 · 2015: 24 · 2014: 11
FWCI
18.34
Type
journal article
Language
en
Update notices
erratum (2014-02-06)
Open access
Licence
Locations
  • The American Journal of Human Genetics (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Explore Bristol Research (submittedVersion, other-oa)
  • Bristol Research (University of Bristol) (submittedVersion, other-oa)
Funders
  • British Heart Foundation (PG/09/022/26739)
  • Medical Research Council (MR/K006584/1)
  • National Institute on Minority Health and Health Disparities (P20MD006899)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords
body mass index, obesity, cardiometabolic traits, type 2 diabetes, coronary artery disease, stroke, fasting blood glucose, fasting insulin, interleukin-6, systolic blood pressure, HDL cholesterol, LDL cholesterol, genetic score, causal effects, genetic epidemiology, cardiovascular risk factors, dyslipidemia, inflammation, insulin resistance
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Blood Glucose, Blood Pressure, Coronary Disease, Diabetes Mellitus, Type 2, Fasting, Female, Humans, Insulin, Cholesterol, HDL, Cholesterol, LDL, Longitudinal Studies, Male, Middle Aged, Phenotype, Prospective Studies, Risk Factors, Selection, Genetic, Sensitivity and Specificity, Meta-Analysis as Topic, Interleukin-6, Body Mass Index, Odds Ratio, Stroke, Polymorphism, Single Nucleotide, White People, Young Adult, Genetic Association Studies, Mendelian Randomization Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review